Updated 06:12 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,842.80 -1.12% CL 88.67 +0.12% BTC 64,299.33 +0.27%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,843 −1.12% BTC $64,299 +0.27% VIX 19.30 +3.21% latest tape · as of 06:12 UTC
The Screen · Financials · Asset Management

Ekttitab Holding Company K.S.C Public

EKTTITAB.AE · DFM · USD · Market cap $135M

Ekttitab Holding Company K.S.C Public, together with its subsidiaries, engages in the investment activities in Kuwait.

FAIL · Does not pass the screen
0.37 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 06:12 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price0.37 USD at the 13 Nov 2026 close
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

FAIR-VALUE RANGE

Our fair-value range: range not available (screen dated 2026-11-13).

Current read
Distribution ?
Screened · screened 2026-11-13
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price0.37 USD
Our investment reviews on this name
2026-11-05Read Distribution0.36+4.2% to today Markup gives way to Distribution after a 15% slide in 5 weeks
2026-10-02Read Markup0.42-11.2% to today Accumulation gives way to Markup
2026-08-27Read Accumulation0.42-11.8% to today Markdown gives way to Accumulation
2026-07-02Read Markdown0.42-10.6% to today ✓First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Ekttitab Holding Company K.S.C Public holds its Distribution at $0.37. The statistical read favours the sellers, held for 13 days.

As held on the ledger · 2026-11-13
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 13 days
Price at the screen$0.37
ValuationN/A trailing · N/A forward price to earnings
Values screenFAIL
Beta0.53
The Workings

Five Screens, Shown in Full

Does not pass. Business activity: conventional financial services (interest-based)

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Its core business involves an activity the values screen does not clear. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Ekttitab Holding Company K.S.C Public does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when EKTTITAB.AE's ethical verdict changes

Today EKTTITAB.AE does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Business, in Plain Words
The fundamentals · plain-English read
EPS, trailing-0.01
Profit margin0.0%currently unprofitable
Return on equity-14.7%not currently earning a positive return on equity
FCF yield0.05%
Current ratio0.01below 1: short-term bills exceed liquid assets
Beta0.53steadier than the market
52-week range0.25 - 0.98
MoatNONE
Market cap$135M

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Kuwait and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

EKTTITAB.AE trades on DFM (the company is based in Kuwait). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-05 Distribution · changed $0.36 -14.8% Entry 9

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 185%. Our forward projection puts the odds of a 10% gain over the next month near 37%.

2026-10-29 Markup $0.42 +0.0% Entry 8

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 185%. Our forward projection puts the odds of a 10% gain over the next month near 37%.

2026-10-16 Markup $0.42 +0.0% Entry 7

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 185%. Our forward projection puts the odds of a 10% gain over the next month near 37%.

2026-10-02 Markup · changed $0.42 -0.7% Entry 6

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 185%. Our forward projection puts the odds of a 10% gain over the next month near 37%.

2026-08-27 Accumulation · changed $0.42 +0.0% Entry 5

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 185%. Our forward projection puts the odds of a 10% gain over the next month near 37%.

2026-07-27 Markdown $0.42 +1.4% Entry 4

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 185%. Our forward projection puts the odds of a 10% gain over the next month near 37%.

2026-07-18 Markdown $0.42 +0.0% Entry 3

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 185%. Our forward projection puts the odds of a 10% gain over the next month near 37%.

2026-07-03 Markdown $0.42 +0.0% Entry 2

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Markdown $0.42 Entry 1

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in EKTTITAB.AE's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $0.46 -5.3% · $948 -5.3%
2 months $0.41 +4.3% · $1,043 +4.3%
3 months $0.39 +11.6% · $1,116 +11.6%
6 months $0.52 -17.4% · $826 -17.4%
1 year $0.15 +184.9% · $2,849 +184.9%
2 years $0.22 +94.2% · $1,942 +94.2%
3 years $0.13 +228.0% · $3,280 +228.0%
5 years $0.23 +85.0% · $1,850 +85.0%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever EKTTITAB.AE does next, these words stay.

Ekttitab Holding Company K.S.C Public · EKTTITAB.AE · Distribution · $0.37
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.